Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 9
2006 1
2007 2
2009 1
2010 2
2011 1
2013 1
2014 1
2016 3
2017 7
2018 10
2019 3
2020 7
2021 4
2022 7
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.
Tanaka Y, Takeda R, Fukushima T, Mikami K, Tsuchiya S, Tamura M, Adachi K, Umemoto T, Asada S, Watanabe N, Morishita S, Imai M, Nagata M, Araki M, Takizawa H, Fukuyama T, Lamagna C, Masuda ES, Ito R, Goyama S, Komatsu N, Takaku T, Kitamura T. Tanaka Y, et al. Among authors: takaku t. Nat Commun. 2022 Jan 12;13(1):271. doi: 10.1038/s41467-021-27928-8. Nat Commun. 2022. PMID: 35022428 Free PMC article.
In silico-labeled ghost cytometry.
Ugawa M, Kawamura Y, Toda K, Teranishi K, Morita H, Adachi H, Tamoto R, Nomaru H, Nakagawa K, Sugimoto K, Borisova E, An Y, Konishi Y, Tabata S, Morishita S, Imai M, Takaku T, Araki M, Komatsu N, Hayashi Y, Sato I, Horisaki R, Noji H, Ota S. Ugawa M, et al. Among authors: takaku t. Elife. 2021 Dec 21;10:e67660. doi: 10.7554/eLife.67660. Elife. 2021. PMID: 34930522 Free PMC article.
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.
Tokuhira M, Kimura Y, Tabayashi T, Watanabe N, Tsuchiya S, Takaku T, Iriyama N, Sato E, Nakazato T, Mitsumori T, Ishikawa M, Fujita H, Kizaki M, Ando M, Hatta Y, Iwanaga E, Kawaguchi T. Tokuhira M, et al. Among authors: takaku t. Int J Hematol. 2023 Aug;118(2):210-220. doi: 10.1007/s12185-023-03606-x. Epub 2023 May 2. Int J Hematol. 2023. PMID: 37129800
Bosutinib-induced lung injury: a report of two cases and literature review.
Watanabe N, Takaku T, Tsukune Y, Yasuda H, Ochiai T, Yamada K, Nakazawa H, Hotta S, Nishimaki T, Takagi H, Takahashi K, Komatsu N, Ando M. Watanabe N, et al. Among authors: takaku t. Int J Hematol. 2022 Jun;115(6):902-905. doi: 10.1007/s12185-022-03304-0. Epub 2022 Feb 28. Int J Hematol. 2022. PMID: 35229254 Free PMC article. Review.
Evaluation of bone marrow aspirates using the automated hematology analyzer Sysmex XN-3000.
Tsuchiya K, Kimura K, Ai T, Yamamoto T, Nagasaka K, Takemura H, Edahiro Y, Saito K, Horiuchi Y, Misawa S, Takaku T, Ando J, Ando M, Miida T, Uchihashi K, Tabe Y. Tsuchiya K, et al. Among authors: takaku t. Int J Lab Hematol. 2023 Aug;45(4):460-468. doi: 10.1111/ijlh.14058. Epub 2023 Mar 12. Int J Lab Hematol. 2023. PMID: 36908045
68 results